StonvexLoading…
StonvexStonvexStonvexCore line items from SCNX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $431.61K | $136.64K | $1.36M | $10.25M |
Operating Income | $-42.59M | $-14.70M | $-4.40M | $-2.92M |
Net Income | $-41.51M | $9.07M | $-17.84M | $-3.47M |
EPS (Diluted) | $-2.70 | $2.48 | $-23.35 | $-6.13 |
Total Assets | $84.18M | $104.85M | $12.53M | $3.71M |
Total Liabilities | $14.06M | $25.78M | $11.99M | $3.37M |
Cash & Equivalents | $6.66M | $308.10K | $151.91K | $1.09M |
Free Cash Flow OCF − CapEx | Not available | $-14.28M | Not available | Not available |
Shares Outstanding | 40.63M | 8.75M | 905.01K | 626.25K |